Where Insight Becomes Change

AntidoteInk is a next-generation mental healthcare publishing platform designed to bridge the gap between breakthrough treatments and real, lasting transformation. We create structured, clinically informed workbooks and tools that help individuals not only experience change, but integrate it into their daily lives.

At a time when mental health innovation is accelerating, AntidoteInk focuses on what comes after: understanding, integration, and measurable progress.

Our materials are built to support individuals undergoing advanced treatments, including ketamine-assisted therapy, while remaining accessible to anyone seeking deeper self-awareness and meaningful personal growth.

Built for Modern Mental Healthcare

Mental health treatment is evolving. AntidoteInk exists to support that evolution.

Our work aligns with emerging modalities such as ketamine-assisted psychotherapy and future psychedelic-based treatments, while remaining grounded in established psychological principles. By combining structured reflection with validated tools and consistent tracking, we help turn subjective experiences into objective progress.

What We Do

AntidoteInk develops high-quality, structured workbooks grounded in evidence-based frameworks and practical application. Each product is designed to:

• Guide reflection before, during, and after therapeutic experiences
• Translate insights into sustainable behavioral change
• Provide consistent, trackable mental health metrics
• Support both independent users and clinical environments

We believe that insight without integration is temporary. Our goal is to make it permanent.

Dr. John Huber

Dr. Huber is a clinical forensic psychologist with more than two decades of experience in mental health, and the Chief Executive Officer of TripSitter.Clinic. His career spans clinical practice, academia, and national media, with a consistent focus on expanding access to effective, evidence-based mental health treatment. As Chairman of Mainstream Mental Health, Dr. Huber has been a leading voice in public education and clinical innovation, bringing both scientific rigor and real-world applicability to the development of AntidoteInk’s platform.

Vincent B. Donadio

Vincent is an entrepreneur and systems-driven operator known for modernizing legacy industries through technology, infrastructure, and strategic execution. He previously held leadership roles at MarijuanaDoctors.com and was a Co-Founder of TripSitter.Clinic, where he focused on building scalable patient-facing systems and operational frameworks. His work has consistently centered on bridging innovation with accessibility—an approach that is highly attuned to AntidoteInk’s mission to translate breakthrough treatments into structured, measurable outcomes.

Jason S. Draizin

Jason was the founder of MarijuanaDoctors.com, one of the earliest and most influential platforms in the medical cannabis industry. As a true first mover, he helped define the infrastructure through which patients could legally and efficiently access alternative treatments at scale, well before mainstream adoption. His work with both MarijuanaDoctors.com and TripSitter.Clinic played a meaningful role in shaping the early landscape of regulated cannabis, and then psychedelics, and helped lay the groundwork for broader acceptance of emerging therapeutic modalities.